Ceragem Posts 1,091% YoY Surge in Operating Profit Last Year... "Reaping the Rewards of Technology Investment"

Ceragem announced on April 13 that, as a result of consistent investment in technology, its consolidated operating profit for the previous year reached KRW 25.8 billion, marking a 1,091% increase compared to the same period the year before. Revenue for the same period rose by 0.7% to KRW 549.8 billion. Net profit also turned positive, reaching KRW 1.9 billion.

Kyungsoo Lee, President and CEO of Ceragem, is explaining the 7-Care solution based on seven health factors. Ceragem

원본보기 아이콘

Ceragem analyzed that its ongoing investment and business structure advancement strategy began to yield substantial results starting last year. The company has promoted portfolio diversification by expanding its product and service areas centered around the '7-Care Solution.'

The 7-Care Solution is an integrated healthcare strategy based on seven health factors, including spine, exercise, and rest. Ceragem enhanced the competitiveness of its flagship products, including the Ministry of Food and Drug Safety-certified spinal care medical device 'Master V Collection' and the massage chair 'Pause M Collection.' At the same time, the company advanced its revenue structure by expanding into new product categories such as the blood circulation improvement medical device 'Celltron Circulation Chair' and the alkaline ion water generator 'Ceragem Balance.'

The strategy to enhance customer experience, centered on offline experiential stores, also proved effective. While main product lines maintained stable revenue streams, new products and services drove additional growth.

Investment in research and development has also translated into results. Ceragem invested KRW 18.9 billion in 2023, KRW 19.1 billion in 2024, and KRW 24.2 billion in 2025, continuing the advancement of technology and development of new products. Going forward, the company plans to further strengthen its stable profit structure by maintaining its focus on technology development investment.

The global business is continuing to expand, especially in emerging markets such as Southeast Asia, India, and Latin America. Ceragem’s strategy is to reorganize its portfolio around markets with high growth potential, thereby securing a foundation for mid- to long-term global growth.

A Ceragem representative stated, "Last year’s performance was more than just a recovery-it marked a turning point where the results of our investments began to be fully reflected. We will continue to reinforce our competitive edge, focusing on the 7-Care Solution and the AI Wellness Home vision, to maintain a stable growth trajectory."

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.